ArticleBMJ open2022

BESPOKE IO protocol: a multicentre, prospective observational study evaluating the utility of ctDNA in guiding immunotherapy in patients with advanced solid tumours.

Pashtoon Murtaza Kasi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.